Literature DB >> 1512460

Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.

K Li1, G J Guidice, K Tamai, H C Do, D Sawamura, L A Diaz, J Uitto.   

Abstract

One-hundred-eighty kilodalton bullous pemphigoid antigen (BPAG2) is recognized by autoantibodies in the sera of patients with blistering skin diseases, bullous pemphigoid (BP), and herpes gestationis (HG). In this study, we have screened a mouse epidermal keratinocyte cDNA library with a 1.0-kb human BPAG2 cDNA, which has been shown to correspond to two collagenous domains (Giudice et al: J Clin Invest 87:734-738, 1991). Screening of the mouse library identified two cDNA clones, the larger one being 1.8 kb in size. Comparison of the mouse amino acid sequences, as deduced from cDNA, with the corresponding human sequences revealed 86% homology. Furthermore, Northern hybridizations of mouse epidermal RNA with these cDNA revealed the presence of an mRNA transcript of approximately 6 kb, the size of the human BPAG2 mRNA. Elucidation of the deduced amino-acid sequences revealed the presence of definitely one and possibly two putative membrane-associated segments, suggesting that the 180-kDa BP antigen is a transmembrane protein. The sequence analysis also identified a 7-amino-acid segment that was predicted by computer analysis to be antigenic. Elucidation of the divergence between the mouse and previously published human and chicken BPAG2 sequences indicated that this protein segment was relatively well conserved. These data suggest, therefore, that the 180-kDa bullous pemphigoid antigen associated with hemidesmosomes is a well-conserved transmembrane protein that may play a critical role in the attachment of epidermis to the underlying basement membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512460     DOI: 10.1111/1523-1747.ep12616611

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.

Authors:  Lan Lin; Eric Bankaitis; Lisa Heimbach; Ning Li; Magnus Abrink; Gunnar Pejler; Lijia An; Luis A Diaz; Zena Werb; Zhi Liu
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 3.  Spectraplakin family proteins - cytoskeletal crosslinkers with versatile roles.

Authors:  Jamie Zhang; Jiping Yue; Xiaoyang Wu
Journal:  J Cell Sci       Date:  2017-07-05       Impact factor: 5.285

4.  The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.

Authors:  Lisa Heimbach; Zhuowei Li; Paula Berkowitz; Minglang Zhao; Ning Li; David S Rubenstein; Luis A Diaz; Zhi Liu
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

5.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Identification of common immunodominant antigens of Eimeria tenella, Eimeria acervulina and Eimeria maxima by immunoproteomic analysis.

Authors:  Lianrui Liu; Xinmei Huang; Jianhua Liu; Wenyu Li; Yihong Ji; Di Tian; Lu Tian; Xinchao Yang; Lixin Xu; Ruofeng Yan; Xiangrui Li; Xiaokai Song
Journal:  Oncotarget       Date:  2017-05-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.